Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on thebmj.com. Although a selection of rapid responses will be included online and in print as readers' letters, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window. Letters are indexed in PubMed.
An average 4 cm height gain... 1.57 inches (1) from an injectable
therapy with unknown later risks to health (2) and questionable benefit to
the individual (3).
By my calculations the cost of growth hormone for that 4cm for a
single child would provide 200,000 doses of measles vaccine or 28 village
pumps for sub-Saharan Africa. Shouldn't global ethics be considered?
1) Deodati A, Cianfarani S. Impact of growth hormone therapy on adult
height of children with idiopathic short stature: systematic review. BMJ
2) J. Bell, K. L. Parker, R. D. Swinford, A. R. Hoffman, T. Maneatis
and B. Lippe. Long-Term Safety of Recombinant Human Growth Hormone in
Children. The Journal of Clinical Endocrinology & Metabolism 2010;
3) Sandberg DE. The psychosocial consequences of short stature: a
review of the evidence. Best Practice & Research Clinical
Endocrinology & Metabolism 2002;16: 449-463 .
Dr Wales prescribes Growth Hormone from all current UK manufacturers for current licensed indications detailed in the BNF for Children.